Search

Search results

How to Improve Adherence to Life-saving Heart Failure Treatments with Potassium Binders

… (see Table 1 ). RLY5016 in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic … the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL-HK) trial was a phase III study that … once daily on days 3-14 (maintenance phase). 63 The Hyperkalemia Randomized Intervention Multidose ZS-9 …

Type:

Article

Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction

… Metrics Article Text Figures & Tables References Article Hyperkalemia and Renin-Angiotensin-Aldosterone System … maximally tolerated dose. However, RAASi may also cause hyperkalemia. As a result of this side-effect, doses of RAASi … needed in these patients is often not reached because of hyperkalemia. Also, submaximal dosing of RAASi may be a …

Type:

Article

CFR - Volume 5 Issue 3 Winter 2019

… inhibitors and HF prevention in type 2 diabetes, hyperkalemia and renin-angiotensin-aldosterone system … | Ebook | Login or register to view PDF. Clinical Practice Hyperkalemia and Renin-Angiotensin-Aldosterone System …

Type:

Edition

Foreword

… drugs and the perceived risk and dangers of RAASi-induced hyperkalemia. Although RAASi agents are well known to improve … of patients in RCTs. The well-known RAASi side-effect of hyperkalemia often leads to down-titration or even … of these are two newly registered agents to manage hyperkalemia, zirconium cyclosilicate and Patiromer. They …

Type:

Article

Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction

… Download Display full size Impaired Renal Function, Hyperkalemia and Hypotension Chronic kidney disease, hyperkalemia and drops in systolic blood pressure due to … across the age spectrum. Hypotension, renal impairment and hyperkalemia increased with age in both treatment groups, but …

Type:

Article

Dilemmas in the Dosing of Heart Failure Drugs: Titrating Diuretics in Chronic Heart Failure

… was no difference in the safety outcomes of incidence of hyperkalemia or change from baseline estimated glomerular … remains unclear. Although uncommon, the evolution of hyperkalemia remains a strong consideration with MRA use. … M, et al. Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a …

Type:

Article

Foreword

… agents in the elderly, including chronic kidney disease, hyperkalemia and drops in systolic blood pressure. They …

Type:

Article

Postpartum Cardiomyopathy and Considerations for Breastfeeding

… In addition, the infant should be monitored for hyperkalemia if sacubitril valsartan is used. 42 …

Type:

Article